Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.86% | 21.94% | -11.59% | 18.18% | -41.35% |
| Total Depreciation and Amortization | 0.88% | -0.52% | 1.64% | -3.02% | 0.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -30.24% | 20.49% | -40.29% | 4.58% | 141.74% |
| Change in Net Operating Assets | 142.51% | -95.84% | -30.73% | -1,335.44% | 103.07% |
| Cash from Operations | 26.45% | 3.65% | -18.59% | -0.44% | 220.68% |
| Capital Expenditure | -21.77% | 16.27% | 14.25% | -28.98% | 23.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -967.20% | 69.44% | -- | 100.00% | 98.15% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.43% | 31.68% | -111.72% | -84.54% | -- |
| Cash from Investing | -20.81% | 29.36% | -63.91% | -46.95% | 74.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 44.75% | -57.74% | -58.63% | 466.46% | 135.87% |
| Repurchase of Common Stock | -5.05% | -3,855.55% | 92.39% | -13.75% | -54.89% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 60.65% | -117.30% | 0.18% | -28.32% | 15.05% |
| Cash from Financing | 2.78% | -839.11% | 37.70% | 141.24% | -28.49% |
| Foreign Exchange rate Adjustments | 130.43% | 119.33% | -176.67% | 687.89% | -96.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 62.30% | -252.91% | -77.46% | 8.48% | 161.39% |